MISSISSAUGA, ONTARIO--(MARKET WIRE)--Aug 28, 2007 -- BioSyent Inc. (“BioSyent”, the “Company”)(CDNX:RX.V - News) today released its second quarter 2007 financial results. Sales for the six months ended June 30, 2007 were $447,946, an increase of 8% versus $413,364 in the same period in 2006. The increase in sales was mainly due to an increase in Canadian orders for Protect-It®. While FeraMAX(TM) shipments to wholesale customers commenced in Q2, these were primarily initial stocking orders as one strength of FeraMAX(TM) was not available until late in the quarter. The first six month sales increase coupled with a 2.6% improvement in product margin, increased gross profit by 13%, from $260,863 in the first six months of 2006 to $294,110 in the first six months of 2007.
